D.E. Shaw & Co
CNTB

D.E. Shaw & Co’s Connect Biopharma Holdings CNTB Stock Holding History

D.E. Shaw & Co’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,750
Closed -$12K – 5232
2022
Q2 		$12K Buy
+13,750
New +$20.3K ﹤0.01% 5107

Other funds holding CNTB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co's CNTB Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Connect Biopharma Holdings (CNTB) in Q3 2022, closing a stake of 13,750 shares — an estimated $12K sold.

D.E. Shaw & Co first reported a position in CNTB in Q2 2022 and held it in 1 quarter. The position peaked at $12K in Q2 2022. 25 funds tracked by Wall St. Rank hold CNTB as of Q3 2022.

  • D.E. Shaw & Co reported no remaining Connect Biopharma Holdings position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 13,750 Connect Biopharma Holdings shares in Q3 2022, an estimated $12K.
  • D.E. Shaw & Co first reported a position in Connect Biopharma Holdings in Q2 2022 and held it in 1 quarter.
  • D.E. Shaw & Co's Connect Biopharma Holdings position peaked at $12K in Q2 2022.
  • 25 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.